197 related articles for article (PubMed ID: 30223985)
1. Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial.
Romani L; Marks M; Sokana O; Nasi T; Kamoriki B; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Steer AC; Kaldor JM
Lancet Glob Health; 2018 Oct; 6(10):e1132-e1138. PubMed ID: 30223985
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial.
Romani L; Marks M; Sokana O; Nasi T; Kamoriki B; Cordell B; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Kaldor JM; Steer AC
Lancet Infect Dis; 2019 May; 19(5):510-518. PubMed ID: 30956111
[TBL] [Abstract][Full Text] [Related]
3. A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali.
Coulibaly YI; Dicko I; Keita M; Keita MM; Doumbia M; Daou A; Haidara FC; Sankare MH; Horton J; Whately-Smith C; Sow SO
PLoS Negl Trop Dis; 2013; 7(5):e2221. PubMed ID: 23675549
[TBL] [Abstract][Full Text] [Related]
4. Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo.
Marks M; Toloka H; Baker C; Kositz C; Asugeni J; Puiahi E; Asugeni R; Azzopardi K; Diau J; Kaldor JM; Romani L; Redman-MacLaren M; MacLaren D; Solomon AW; Mabey DCW; Steer AC
Clin Infect Dis; 2019 Mar; 68(6):927-933. PubMed ID: 29985978
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin.
Marks M; Romani L; Sokana O; Neko L; Harrington R; Nasi T; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Kaldor JM; Steer AC
Clin Infect Dis; 2020 Apr; 70(8):1591-1595. PubMed ID: 31131410
[TBL] [Abstract][Full Text] [Related]
6. Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study).
Lake SJ; Phelan SL; Engelman D; Sokana O; Nasi T; Boara D; Gorae C; Schuster T; Grobler AC; Osti MH; Andrews R; Marks M; Whitfeld MJ; Romani L; Kaldor J; Steer A
BMJ Open; 2020 Aug; 10(8):e037305. PubMed ID: 32868360
[TBL] [Abstract][Full Text] [Related]
7. Safety of mass drug coadministration with ivermectin, diethylcarbamazine, albendazole, and azithromycin for the integrated treatment of neglected tropical diseases: a cluster randomized community trial.
John LN; Gonzalez-Beiras C; Vall-Mayans M; Kolmau R; Houinei W; Wangi J; Marks M; Mitja O
Lancet Reg Health West Pac; 2022 Jan; 18():100293. PubMed ID: 35024646
[TBL] [Abstract][Full Text] [Related]
8. Control of scabies in a tribal community using mass screening and treatment with oral ivermectin -A cluster randomized controlled trial in Gadchiroli, India.
Behera P; Munshi H; Kalkonde Y; Deshmukh M; Bang A
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009330. PubMed ID: 33861741
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma.
Marks M; Sokana O; Nachamkin E; Puiahi E; Kilua G; Pillay A; Bottomley C; Solomon AW; Mabey DC
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004927. PubMed ID: 27551787
[TBL] [Abstract][Full Text] [Related]
10. Community control strategies for scabies: A cluster randomised noninferiority trial.
Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Schuster T; Grobler AC; Engelman D; Robinson LJ; Kaldor JM; Steer AC
PLoS Med; 2021 Nov; 18(11):e1003849. PubMed ID: 34758017
[TBL] [Abstract][Full Text] [Related]
11. Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in Ethiopia.
McPherson S; Tafese G; Tafese T; Behaksra SW; Solomon H; Oljira B; Miecha H; Debebe KA; Kebede B; Gebre T; Kebede F; Seife F; Tadesse F; Mammo B; Aseffa A; Solomon AW; Mabey DCW; Marks M; Gadisa E
EClinicalMedicine; 2023 May; 59():101984. PubMed ID: 37152362
[TBL] [Abstract][Full Text] [Related]
12. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
[TBL] [Abstract][Full Text] [Related]
13. The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008106. PubMed ID: 32176703
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.
Fraser-Hurt N; Bailey RL; Cousens S; Mabey D; Faal H; Mabey DC
Bull World Health Organ; 2001; 79(7):632-40. PubMed ID: 11477966
[TBL] [Abstract][Full Text] [Related]
15. Mass Drug Administration for Scabies Control in a Population with Endemic Disease.
Romani L; Whitfeld MJ; Koroivueta J; Kama M; Wand H; Tikoduadua L; Tuicakau M; Koroi A; Andrews R; Kaldor JM; Steer AC
N Engl J Med; 2015 Dec; 373(24):2305-13. PubMed ID: 26650152
[TBL] [Abstract][Full Text] [Related]
16. Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children.
Whitty CJ; Glasgow KW; Sadiq ST; Mabey DC; Bailey R
Pediatr Infect Dis J; 1999 Nov; 18(11):955-8. PubMed ID: 10571428
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review.
McPherson S; Solomon AW; Seife F; Solomon H; Gebre T; Mabey DCW; Marks M
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011224. PubMed ID: 37315102
[TBL] [Abstract][Full Text] [Related]
18. Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital
Harrison MA; Harding-Esch EM; Marks M; Pond MJ; Butcher R; Solomon AW; Zhou L; Tan N; Nori AV; Kako H; Sokana O; Mabey DCW; Sadiq ST
Sex Transm Infect; 2019 Nov; 95(7):522-528. PubMed ID: 30981999
[TBL] [Abstract][Full Text] [Related]
19. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
Gebre T; Ayele B; Zerihun M; Genet A; Stoller NE; Zhou Z; House JI; Yu SN; Ray KJ; Emerson PM; Keenan JD; Porco TC; Lietman TM; Gaynor BD
Lancet; 2012 Jan; 379(9811):143-51. PubMed ID: 22192488
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics for trachoma.
Evans JR; Solomon AW; Kumar R; Perez Á; Singh BP; Srivastava RM; Harding-Esch E
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD001860. PubMed ID: 31554017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
